Burosumab (Anti-FGF23)

Burosumab (Anti-FGF23) is a neutralizing antibody, targeting human fibroblast growth factor 23 (FGF23). It can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia. MW: 145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2499
• Sku #: A2499-1mg*5